Abstract
One of the common causes of failure in dacryocystorhinostomy for nasolacrimal duct obstruction (NLDO) is mucosal scarring and fibrosis around the ostium. Steroid and mitomycin C (MMC) can potentially reduce scarring by their action on the inflammatory and proliferative phase of wound healing, respectively. The purpose of this study is to evaluate the safety and efficacy of combined usage of adjunctive MMC and intranasal triamcinolone (TA) in endonasal endoscopic dacryocystorhinostomy (EE-DCR). This is a retrospective interventional case series. All patients underwent mechanical EE-DCR in two regional hospitals in Hong Kong from January 2005 to December 2006 were included. All received intraoperative MMC application for 5 min and gelfoam soaked with TA onto the ostium. Main outcome measures include the anatomical and functional success rate at follow-up at least 6 months after operation. Other outcomes include complications occurred during and after operation. A total of 73 EE-DCR were performed in 69 patients. Three patients had simultaneous bilateral DCR; one had sequential DCRs for both sides. At the last follow-up, anatomical success was achieved in 68 cases (93 %) and both anatomical with functional success in 67 cases (92 %). No major complication was observed. Minor complications included asymptomatic mucosal adhesion between the nasal septum and lateral nasal wall in one patient and moderate secondary hemorrhage in another. EE-DCR with adjunctive MMC and TA is a safe and successful procedure for the treatment of NLDO.
Similar content being viewed by others
References
Lee DW, Chai CH, Loon SC (2010) Primary external dacryocystorhinostomy versus primary endonasal dacryocystorhinostomy: a review. Clin Exp Ophthalmol 38(4):418–426
Hartikainen J, Grenman R, Puukka P, Seppa H (1998) Prospective randomized comparison of external dacryocystorhinostomy and endonasal laser dacryocystorhinostomy. Ophthalmology 105(6):1106–1113
Moore WM, Bentley CR, Olver JM (2002) Functional and anatomic results after two types of endoscopic endonasal dacryocystorhinostomy: surgical and holmium laser. Ophthalmology 109(8):1575–1582
Dolman PJ (2003) Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology 110(1):78–84
Ben Simon GJ, Joseph J, Lee S, Schwarcz RM, McCann JD, Goldberg RA (2005) External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center. Ophthalmology 112(8):1463–1468
Barmettler A, Erlich J, Lelli G Jr (2013) Current preferences and reported success rates in dacryocystorhinostomy amongst ASOPRS members. Orbit 32(1):20–26
Tsirbas A, Wormald PJ (2003) Mechanical endonasal dacryocystorhinostomy with mucosal flaps. Br J Ophthalmol 87(1):43–47
Codere F, Denton P, Corona J (2010) Endonasal dacryocystorhinostomy: a modified technique with preservation of the nasal and lacrimal mucosa. Ophthalmic Plast Reconstr Surg 26(3):161–164
Zilelioglu G, Ugurbas SH, Anadolu Y, Akiner M, Akturk T (1998) Adjunctive use of mitomycin C on endoscopic lacrimal surgery. Br J Ophthalmol 82(1):63–66
Prasannaraj T, Kumar BY, Narasimhan I, Shivaprakash KV (2012) Significance of adjunctive mitomycin C in endoscopic dacryocystorhinostomy. Am J Otolaryngol 33(1):47–50
Lee DA (1994) Antifibrosis agents and glaucoma surgery. Invest Ophthalmol Vis Sci 35(11):3789–3791
Dolmetsch AM (2010) Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults. Ophthalmology 117(5):1037–1040
Zeldovich A, Ghabrial R (2009) Revision endoscopic dacryocystorhinostomy with betamethasone injection under assisted local anaesthetic. Orbit 28(6):328–331
Cheng AC, Wong AC, Sze AM, Yuen HK (2009) Limited nasal septoplasty by ophthalmologists during endonasal dacryocystorhinostomy: is it safe? Ophthalmic Plast Reconstr Surg 25(4):293–295
Yigit O, Samancioglu M, Taskin U, Ceylan S, Eltutar K, Yener M (2007) External and endoscopic dacryocystorhinostomy in chronic dacryocystitis: comparison of results. Eur Arch Otorhinolaryngol 264:879–885
Anijeet D, Dolan L, Macewen CJ (2011) Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction. Cochrane Database Syst Rev 19(1):CD007097
Woog JJ, Kennedy RH, Custer PL, Kaltreider SA, Meyer DR, Camara JG (2001) Endonasal dacryocystorhinostomy: a report by the American Academy of Ophthalmology. Ophthalmology 108(12):2369–2377
Ali MJ, Baig F, Lakshman M, Naik MN (2015) Electron microscopic features of nasal mucosa treated with topical and circumostial injection of mitomycin C: implications in dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg 31(2):103–107
Ali MJ, Mariappan I, Maddileti S, Ali MH, Naik MN (2013) Mitomycin C in dacryocystorhinostomy: the search for the right concentration and duration: a fundamental study on human nasal mucosa fibroblasts. Ophthalmic Plast Reconstr Surg 29(6):469–474
Kao SC, Liao CL, Tseng JH et al (1997) Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 104:86–91
Yeatts RP, Neves RB (1999) Use of mitomycin C in repeat dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg 15(1):19–22
Camara JG, Bengzon AU, Henson RD (2000) The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg 16(2):114–118
Dolmetsch AM, Gallon MA, Holds JB (2008) Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children. Ophthalmic Plast Reconstr Surg 24:390–393
Kamal S, Ali MJ, Naik MN (2014) Circumostial injection of mitomycin C (COS-MMC) in external and endoscopic dacryocystorhinostomy: efficacy, safety profile, and outcomes. Ophthalmic Plast Reconstr Surg 30(2):187–190
Leibovitch I, Prabhakaran VC, Davis G, Selva D (2007) Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation. Arch Ophthalmol 125(12):1647–1651
Ebner R, Devoto MH, Weil D et al (2004) Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 88(11):1380–1386
Kalina PH, Erie JC, Rosenbaum L (1995) Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol 113(7):867–869
Woo KI, Maeng HS, Kim YD (2011) Characteristics of intranasal structures for endonasal dacryocystorhinostomy in asians. Am J Ophthalmol 152(3):491–498
Conflict of interest
No conflicting relationship exists for any author.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, E.Y., Cheng, A.C., Wong, A.C. et al. Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy. Int Ophthalmol 36, 105–110 (2016). https://doi.org/10.1007/s10792-015-0088-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-015-0088-0